Filtered By:
Condition: Bleeding
This page shows you your search results in order of relevance. This is page number 13.
Order by Relevance | Date
Total 57721 results found since Jan 2013.
Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts
CONCLUSIONS: The meta-analyses of three studies for ticlopidine (an antiplatelet treatment), which all used the same dose of treatment but with a short follow-up of only one month, suggest ticlopidine may have a beneficial effect as an adjuvant treatment to increase the patency of AVFs and AVGs in the short term. There was insufficient evidence to determine if there was a difference in graft patency between placebo and other treatments such as aspirin, fish oil, clopidogrel, dipyridamole, dipyridamole plus aspirin, warfarin, sulphinpyrazone and GTN patch. The certainty of the evidence was low to moderate due to short follo...
Source: Cochrane Database of Systematic Reviews - July 23, 2021 Category: General Medicine Authors: Imran Mohamed Mohamad Fathul Aizat Kamarizan Antonio Da Silva Source Type: research
Anticoagulant therapy for women: implications for menstruation, pregnancy, and lactation
Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):467-473. doi: 10.1182/hematology.2022000401.ABSTRACTEstrogen exposure, in the setting of pregnancy, the postpartum state, combined hormonal contraceptives (CHCs), or hormone therapy use, has been clearly associated with increased rates of venous thromboembolism (VTE). Although recurrence rates are low in these settings, up to 70% of anticoagulated menstruating individuals experience abnormal or heavy menstrual bleeding (HMB), which commonly results in iron deficiency with or without anemia. Patients taking rivaroxaban appear to experience higher rates of HMB compar...
Source: Hematology ASH Education Program - December 9, 2022 Category: Hematology Authors: Emma DeLoughery Bethany Samuelson Bannow Source Type: research
